软通道微创技术手术治疗高血压脑出血临床应用研究

The Clinical Study of Soft Channel Minimally Invasive Technology Operation in Treating Hypertensive Cerebral Hemorrhage

目的:探讨应用软通道微创技术治疗高血压脑出血的疗效。方法:选取2013年4月-2014年7月本院神经外科因高血压诱发脑出血而应用软通道微创技术治疗的患者19例为观察组;同时随机选取同期采用开颅手术的19例患者为对照组,对比分析两组患者的临床疗效。结果:两组在治疗总有效率方面,观察组具有明显优势,其中治疗7 d后的总有效率为84.2%,明显高于对照组的63.2%,治疗3个月的总有效率94.7%,明显高于对照组73.7%,差异均有统计学意义(P<0.05)。两组的神经功能缺损程度及并发症发生率比较差异均有统计学意义(P<0.05)。结论:应用软通道微创技术治疗高血压脑出血疗效明显,具有神经功能损伤小、并发症少的优势,值得在临床中推广使用。

Objective：To explore the clinical effect of soft channel minimally invasive technology operation in treating hypertensive cerebral hemorrhage.Method：19 patents with soft channel minimally invasive technology operation in our hospital from April 2013 to July 2014 were chosen as the observation group,and at the same time 19 cases with craniotomy operation were chosen as the control group.The clinical effects of the two groups were compared and analyzed. Result：Compared with the control group, the observation group had obvious advantages on the treatment efficiency, at the same time, the total efficiency after 7 days of the observation group （84.2%） was significantly higher than that of the control group （63.2%）, the total efficiency after 3 months of the observation group （94.7%） was significantly higher than that of the control group（73.7%）, and the obvious differences had statistical significance （P〈0.05）.The nerve function defect degree and the incidence of complications of the two groups were statistically significant （P〈0.05）.Conclusion：The soft channel minimally invasive technology operation has obvious effects on treating hypertensive cerebral hemorrhage, and it is worthy of applications in clinic with the advantages of less nerve nerve function damage and lower incidence of disease.